QR код

Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysis

IntroductionCombinations of immune checkpoint inhibitors (ICIs) and angiogenesis inhibitors (AIs) have been investigated for the treatment of several tumor types. Both ICIs and AIs may lead to cardiovascular adverse events, and their combination may potentially increase the risk for cardiovascular t...

Повний опис

Збережено в:
Бібліографічні деталі
Автори: Alessandro Inno, Antonello Veccia, Giorgio Madonia, Alvise Berti, Roberto Bortolotti, Lorena Incorvaia, Antonio Russo, Orazio Caffo, Stefania Gori
Формат: Artigo
Мова:Inglês
Опубліковано: Frontiers Media S.A. 2024-02-01
Серія:Frontiers in Cardiovascular Medicine
Предмети:
Онлайн доступ:https://www.frontiersin.org/articles/10.3389/fcvm.2024.1309100/full
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!